We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
264 hedge funds and large institutions have $715M invested in Iovance Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 103 increasing their positions, 64 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
103% more call options, than puts
Call options by funds: $12M | Put options by funds: $5.94M
61% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 64
55% more capital invested
Capital invested by funds: $462M → $715M (+$253M)
46% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 35
7.03% more ownership
Funds ownership: 58.87% → 65.9% (+7%)
4% more funds holding
Funds holding: 253 → 264 (+11)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
264
Holders Change
+11
Holders Change %
+4.35%
% of All Funds
3.21%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
51
Increased
103
Reduced
64
Closed
35
Calls
$12M
Puts
$5.94M
Net Calls
+$6.1M
Net Calls Change
+$3.1M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$18.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$15.9M |
| 3 |
HF
HRT Financial
New York
|
+$9.22M |
| 4 |
D.E. Shaw & Co
New York
|
+$8.68M |
| 5 |
Morgan Stanley
New York
|
+$8.35M |
